Xiaoyang He

Gansu University of Traditional Chinese Medicine

Papers

Total Citations

H-Index

About

Xiaoyang He is a pioneering thoracic surgeon whose research focuses on advancing minimally invasive surgical techniques for lung cancer treatment, particularly through robotic-assisted approaches. His most notable contribution is the validation of biportal robot-assisted lobectomy, a novel procedure that reduces surgical trauma while maintaining oncologic efficacy. In his landmark 2021 study, He demonstrated the safety and effectiveness of this technique through a retrospective analysis of 18 patients, reporting favorable short-term outcomes including reduced postoperative pain and faster recovery times. This work, which has garnered 9 citations, represents an important step in refining robotic thoracic surgery protocols. He’s research addresses critical gaps in the transition from traditional multiportal to more streamlined biportal approaches, potentially expanding access to robotic surgery for lung cancer patients. His findings contribute to the growing body of evidence supporting the adoption of advanced robotic platforms in thoracic oncology, positioning him as an emerging voice in the field of minimally invasive thoracic surgery.